Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

Businessweek Archives

Mark J. Levin, Millennium Pharmaceuticals


The Top 25 Managers -- The Top Entrepreneurs

Mark J. Levin, Millennium Pharmaceuticals

Mark J. Levin and his wife are fixing up a 33-room mansion in Rhode Island. There's also a llama, two peacocks, and nine African sika deer to care for. But those projects are nothing compared to Levin's transformation of tiny biotech startup Millennium Pharmaceuticals Inc. (MLNM) Levin, 50, plans to use the knowledge contained in the human genome to revolutionize the pharmaceutical industry. Millennium, which has five drugs in clinical trials, will market its first, for leukemia, in early 2001. He has raised about $1.8 billion from big drug companies and others. Some of that will no doubt be used to buy up competitors and extend the house that Levin built.


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus